Mazzone, Elena Stacy
 Distribuzione geografica
Continente #
NA - Nord America 449
EU - Europa 372
AS - Asia 93
SA - Sud America 8
AF - Africa 2
Totale 924
Nazione #
US - Stati Uniti d'America 444
IT - Italia 155
SE - Svezia 70
IE - Irlanda 48
SG - Singapore 38
DE - Germania 23
RU - Federazione Russa 22
CN - Cina 16
FR - Francia 14
IN - India 11
GB - Regno Unito 9
HK - Hong Kong 6
CH - Svizzera 4
FI - Finlandia 4
IL - Israele 4
IR - Iran 4
NL - Olanda 4
PE - Perù 4
TR - Turchia 4
CA - Canada 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
JP - Giappone 3
EG - Egitto 2
ES - Italia 2
HR - Croazia 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
KR - Corea 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UA - Ucraina 1
VN - Vietnam 1
Totale 924
Città #
Chandler 108
Ashburn 81
New York 47
Dublin 40
Rome 23
Milan 22
Singapore 21
Moscow 14
Chicago 10
Los Angeles 10
Marseille 10
Palermo 10
Pune 10
Princeton 8
Boston 7
San Mateo 7
Munich 6
Secaucus 5
Ancona 4
Edinburgh 4
Fairfield 4
Florence 4
Hong Kong 4
Kiel 4
Lima 4
Shenzhen 4
Turin 4
Wilmington 4
Bern 3
Bremen 3
Brno 3
Bucaramanga 3
Busto Arsizio 3
Harrisburg 3
Helsinki 3
Naples 3
Triggiano 3
Amsterdam 2
Barbarano Vicentino 2
Beijing 2
Bergamo 2
Bologna 2
Cairo 2
Conegliano 2
Copenhagen 2
Frankfurt am Main 2
Genoa 2
Hangzhou 2
Istanbul 2
Kazan' 2
Menlo Park 2
Oegstgeest 2
Perafita 2
Pescara 2
Piacenza 2
Priolo Gargallo 2
Redmond 2
Royal Oak 2
San Francisco 2
San Martino in Rio 2
Sandston 2
Santa Clara 2
Shanghai 2
Springfield 2
Tokyo 2
Toronto 2
Tribano 2
Washington 2
Zagreb 2
Albignasego 1
Almaty 1
Andover 1
Bangkok 1
Bari 1
Bisignano 1
Bratislava 1
Breckenridge 1
Brussels 1
Cattolica 1
Cedar Knolls 1
Central 1
Cinisello Balsamo 1
Deiva Marina 1
Edmonton 1
Forest City 1
Grassobbio 1
Gricignano di Aversa 1
Gunzenhausen 1
Hanoi 1
Kish 1
Klausen 1
Lappeenranta 1
Las Vegas 1
Leawood 1
Lomazzo 1
London 1
Macao 1
Madrid 1
Manchester 1
Mantova 1
Totale 601
Nome #
Performance of Upper Limb module for Duchenne muscular dystrophy 111
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 74
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 63
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 51
Clinical Variability in Spinal Muscular Atrophy Type III. 47
Our Experience on Temporal Bone Fractures: Retrospective Analysis of 141 Cases 41
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 39
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 38
First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy 37
Revised upper limb module for spinal muscular atrophy: Development of a new module 36
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 35
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 34
Sleep disorders in spinal muscular atrophy 30
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 30
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 29
Old measures and new scores in spinal muscular atrophy patients 29
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 26
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 23
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 21
Early neurodevelopmental assessment in Duchenne muscular dystrophy 20
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report 18
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 17
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 16
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool 14
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 13
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients 10
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability 9
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 7
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 7
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 7
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy 4
Daily salbutamol in young patients with SMA type II 4
Correction: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-Month changes 3
Reliability of the North Star Ambulatory Assessment in a multicentric setting 3
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 3
Assessing upper limb function in nonambulant SMA patients: Development of a new module 2
Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM 2
Totale 953
Categoria #
all - tutte 6.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/202293 11 0 0 19 4 6 3 10 4 6 18 12
2022/2023359 19 30 26 44 30 59 17 34 51 12 20 17
2023/2024467 22 83 12 23 15 87 40 43 11 21 50 60
2024/202532 22 10 0 0 0 0 0 0 0 0 0 0
Totale 953